Current therapeutic strategies for AD encompass a range of mechanisms, including the removal of Aβ plaques, addressing the accumulation of tau proteins, modulating the function of apolipoprotein-E (ApoE), neuroprotection, and managing neuroinflammatory responses. Here, MAPT is linked to Alzheimer disease.